๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
49 KB
Volume
14
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparison of the tolerability and effic
โœ C. J. Kyle; Hans Erik Hรธpfner Petersen; Kerstin Fredricson Overรธ ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 2 views

The enhanced sensitivity of the elderly to the side effects produced by tricyclic antidepressants (TCAs), and the frequency and type of adverse events, have made the treatment of depression in this group difficult. The selective serotonin reuptake inhibitors (SSRIs) have been reported to produce sig

The efficacy and tolerability of divalpr
โœ Mark E. Kunik; Lucy Puryear; Claudia A. Orengo; Victor Molinari; Richard H. Work ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 1 views

Behavioral disturbances are commonly encountered in elderly demented patients. The records of all patients admitted to a geropsychiatric inpatient unit within a 2-year period who had a primary diagnosis of dementia and an accompanying behavioral disturbance treated with divalproex sodium were review

Comparative efficacy of nonheated and he
โœ Richard S. Schwartz; Nadia P. Ewing; Toni J. Gorenc; Joel A. Spero ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 354 KB ๐Ÿ‘ 1 views

To determine if heat-treated factor IX complex concentrate is as effective as nonheated factor IX complex concentrate for treatment of subjects with hemophilia A and antifactor Vlll antibodies (inhibitor patients), we have retrospectively reviewed consecutive home treatment records of ten inhibitor

Pravastatin compared to bezafibrate in t
โœ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 1 views

Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva